Vascular Endothelial Over-Expression of Human Soluble Epoxide Hydrolase (Tie2-sEH Tr) Attenuates Coronary Reactive Hyperemia in Mice: Role of Oxylipins and ω-Hydroxylases.

Vascular Endothelial Over-Expression of Human Soluble Epoxide Hydrolase (Tie2-sEH Tr) Attenuates Coronary Reactive Hyperemia in Mice: Role of Oxylipins and ω-Hydroxylases.

Cytochromes P450 metabolize arachidonic acid (AA) into two vasoactive oxylipins with opposing biologic effects: epoxyeicosatrienoic acids (EETs) and omega-(ω)-terminal hydroxyeicosatetraenoic acids (HETEs). EETs have numerous beneficial physiological effects, including vasodilation and protection ag...

Full description

Bibliographic Details
Main Authors:	Ahmad Hanif, Matthew L Edin, Darryl C Zeldin, Christophe Morisseau, John R Falck, Mohammed A Nayeem
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2017-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0169584

Similar Items

Effect of Soluble Epoxide Hydrolase on the Modulation of Coronary Reactive Hyperemia: Role of Oxylipins and PPARγ.
by: Ahmad Hanif, et al.
Published: (2016-01-01)

EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides
by: Martina Decker, et al.
Published: (2012-10-01)

Repositioning of Quinazolinedione-Based Compounds on Soluble Epoxide Hydrolase (sEH) through 3D Structure-Based Pharmacophore Model-Driven Investigation
by: Erica Gazzillo, et al.
Published: (2022-06-01)

Misclassification of PfEH1 and PfEH2 as Epoxide Hydrolases
by: Michael Arand, et al.
Published: (2017-05-01)

Reply to “Misclassification of PfEH1 and PfEH2 as Epoxide Hydrolases”
by: Daniel E. Goldberg, et al.
Published: (2017-05-01)

Activity of sEH and Oxidant Status during Systemic Bovine Coliform Mastitis
by: Vengai Mavangira, et al.
Published: (2021-05-01)

Ibuprofen alters epoxide hydrolase activity and epoxy-oxylipin metabolites associated with different metabolic pathways in murine livers
by: Shuchita Tiwari, et al.
Published: (2021-03-01)

Association of the sEH gene promoter polymorphisms and haplotypes with preeclampsia
by: Sarı İsmail, et al.
Published: (2020-01-01)

Sex-Specific Response of the Brain Free Oxylipin Profile to Soluble Epoxide Hydrolase Inhibition
by: Jennifer E. Norman, et al.
Published: (2023-02-01)

Editorial: Clinical Paths for Soluble Epoxide Hydrolase Inhibitors
by: John D. Imig, et al.
Published: (2020-09-01)

Generation and characterization of epoxide hydrolase 3 (EPHX3)-deficient mice.
by: Samantha L Hoopes, et al.
Published: (2017-01-01)

Soluble Epoxide Hydrolase Derived Linoleic Acid Oxylipins, Small Vessel Disease Markers, and Neurodegeneration in Stroke
by: Di Yu, et al.
Published: (2023-01-01)

Differential Effects of sEH Inhibitors on the Proliferation and Migration of Vascular Smooth Muscle Cells
by: Hyo Seon Kim, et al.
Published: (2017-12-01)

Effect Of Dual sEH/COX-2 Inhibition on Allergen-Induced Airway Inflammation
by: Mythili Dileepan, et al.
Published: (2019-09-01)

Epoxy-Oxylipins and Soluble Epoxide Hydrolase Metabolic Pathway as Targets for NSAID-Induced Gastroenteropathy and Inflammation-Associated Carcinogenesis
by: Ryan D. Jones, et al.
Published: (2019-06-01)

Design and Potency of Dual Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase Inhibitors
by: Sean D. Kodani, et al.
Published: (2018-10-01)

Cytochrome P450-soluble epoxide hydrolase derived linoleic acid oxylipins and cognitive performance in type 2 diabetes
by: Natasha Z. Anita, et al.
Published: (2023-07-01)

Deficiency of Soluble Epoxide Hydrolase Protects Cardiac Function Impaired by LPS-Induced Acute Inflammation
by: Victor Samokhvalov, et al.
Published: (2019-01-01)

In Vitro and In Silico Insights into sEH Inhibitors with Amide-Scaffold from the Leaves of Capsicum chinense Jacq.
by: Jang Hoon Kim, et al.
Published: (2018-01-01)

Effects of inflammation and soluble epoxide hydrolase inhibition on oxylipin composition of very low‐density lipoproteins in isolated perfused rat livers
by: Rachel E. Walker, et al.
Published: (2021-02-01)

Effects of Individual Circulating FFAs on Plasma and Hepatic FFA Epoxides, Diols, and Epoxide-Diol Ratios as Indices of Soluble Epoxide Hydrolase Activity
by: Young Taek Oh, et al.
Published: (2023-06-01)

Soluble Epoxide Hydrolase Inhibition by <i>t</i>-TUCB Promotes Brown Adipogenesis and Reduces Serum Triglycerides in Diet-Induced Obesity
by: Haley Overby, et al.
Published: (2020-09-01)

Dual sEH/COX-2 Inhibition Using PTUPB—A Promising Approach to Antiangiogenesis-Induced Nephrotoxicity
by: Wojciech K. Jankiewicz, et al.
Published: (2021-12-01)

Soluble Epoxide Hydrolase in Aged Female Mice and Human Explanted Hearts Following Ischemic Injury
by: K. Lockhart Jamieson, et al.
Published: (2021-02-01)

Catalytic activities of mammalian epoxide hydrolases with cis and trans fatty acid epoxides relevant to skin barrier function
by: Haruto Yamanashi, et al.
Published: (2018-04-01)

Substantially improving the enantioconvergence of PvEH1, a Phaseolus vulgaris epoxide hydrolase, towards m-chlorostyrene oxide by laboratory evolution
by: Xun-Cheng Zong, et al.
Published: (2019-11-01)

Occurrence of urea-based soluble epoxide hydrolase inhibitors from the plants in the order Brassicales.
by: Seiya Kitamura, et al.
Published: (2017-01-01)

Epoxide Hydrolases: Multipotential Biocatalysts
by: Marek Bučko, et al.
Published: (2023-04-01)

Antioxidant and anti-inflammatory activity through inhibition of NF-κB and sEH of some citrus peel and phytoconstituent characteristics
by: Yesi Desmiaty, et al.
Published: (2024-02-01)

The Generation of a Nanobody-Based ELISA for Human Microsomal Epoxide Hydrolase
by: Qiyi He, et al.
Published: (2023-09-01)

Soluble Epoxide Hydrolase Is Associated with Postprandial Anxiety Decrease in Healthy Adult Women
by: Nhien Nguyen, et al.
Published: (2022-10-01)

Effect of soluble epoxide hydrolase polymorphism on substrate and inhibitor selectivity and dimer formation[S]
by: Christophe Morisseau, et al.
Published: (2014-06-01)

Pharmaceutical Effects of Inhibiting the Soluble Epoxide Hydrolase in Canine Osteoarthritis
by: Cindy B. McReynolds, et al.
Published: (2019-05-01)

Mammalian soluble epoxide hydrolase is identical to liver hepoxilin hydrolase
by: Annette Cronin, et al.
Published: (2011-04-01)

Hyperglycemia disrupted the integrity of the blood‐brain barrier following diffuse axonal injury through the sEH/NF‐κB pathway
by: Xing Wei, et al.
Published: (2023-12-01)

Soluble Epoxide Hydrolase Contributes to Cell Senescence and ER Stress in Aging Mice Colon
by: Weicang Wang, et al.
Published: (2023-02-01)

Soluble Epoxide Hydrolase Hepatic Deficiency Ameliorates Alcohol-Associated Liver Disease
by: Aline Mello, et al.
Published: (2021-01-01)

Selection of Potent Inhibitors of Soluble Epoxide Hydrolase for Usage in Veterinary Medicine
by: Diyala S. Shihadih, et al.
Published: (2020-08-01)

Soluble Epoxide Hydrolase and Diabetes Complications
by: Natasha Z. Anita, et al.
Published: (2022-06-01)

Relative Importance of Soluble and Microsomal Epoxide Hydrolases for the Hydrolysis of Epoxy-Fatty Acids in Human Tissues
by: Christophe Morisseau, et al.
Published: (2021-05-01)